Ceftolozane/tazobactam dose regimens in severely/morbidly obese patients with complicated intra-abdominal infection or complicated urinary tract infection

AJ Xiao, JA Huntington, J Long, L Caro - International journal of …, 2018 - Elsevier
Ceftolozane/tazobactam is approved for treatment of complicated intra-abdominal infection
(cIAI) and complicated urinary tract infection (cUTI) with renal function-based dose …
被引用次数：10 相关文章

Ceftolozane/tazobactam dose regimens in severely/morbidly obese patients with complicated intra-abdominal infection or complicated urinary tract infection

AJ Xiao, JA Huntington, J Long… - International journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Ceftolozane/tazobactam is approved for treatment of complicated intra-abdominal infection
(cIAI) and complicated urinary tract infection (cUTI) with renal function-based dose …

Ceftolozane/tazobactam dose regimens in severely/morbidly obese patients with complicated intra-abdominal infection or complicated urinary tract infection.

AJ Xiao, JA Huntington, J Long… - International Journal of …, 2018 - europepmc.org
Ceftolozane/tazobactam is approved for treatment of complicated intra-abdominal infection
(cIAI) and complicated urinary tract infection (cUTI) with renal function-based dose …

Ceftolozane/tazobactam dose regimens in severely/morbidly obese patients with complicated intra-abdominal infection or complicated urinary tract infection.

AJ Xiao, JA Huntington, LJM Long JianMin, L Caro - 2018 - cabidigitallibrary.org
Ceftolozane/tazobactam is approved for treatment of complicated intra-abdominal infection
(cIAI) and complicated urinary tract infection (cUTI) with renal function-based dose …

[引用][C] Ceftolozane/tazobactam dose regimens in severely/morbidly obese patients with complicated intra-abdominal infection or complicated urinary tract infection

AJ Xiao, JA Huntington, J Long, L Caro - 2018